This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Mergers & Acquisitions

Jun. 13, 2014

Dealmakers

A roundup of recent mergers and acquisitions and financing activity and the lawyers involved.


Mergers & Acquisitions

Sullivan helps drugmaker sell to Merck


Sullivan & Cromwell LLP advised hepatitis C drug developer Idenix Pharmaceuticals Inc. in its $3.85 billion sale to Merck & Co., a deal announced Monday.


Merck will pay $24.50 per share in cash under the terms of the deal. The company is employing a two-step tender offer and is acquiring Idenix through a subsidiary. Boards of directors at both com...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up